A. Dezellus

Evolution of serum Anti-Müllerian Hormone (AMH) level in young women treated with chemotherapy for breast cancer according to basal AMH level.

A. Reignier, P. Barrière, T. Fréour, 2020, European journal of obstetrics, gynecology, and reproductive biology.

Healthcare system barriers of breast and thyroid screening for childhood and young adulthood cancer survivors in France: A qualitative study of the DeNaCaPST programme at one year

L. Claude, A. Dumas, C. Oudot, 2019, Clinical Research and Trials.

Abstract P4-16-02: Fertility preservation before neoadjuvant or adjuvant chemotherapy for breast cancer: Final results of PRESAGE trial

M. Campone, S. Lavau, C. Lefeuvre-plesse, 2019, Poster Session Abstracts.

Prospective evaluation of serum anti-Müllerian hormone dynamics in 250 women of reproductive age treated with chemotherapy for breast cancer.

T. Delozier, M. Campone, M. Mouret-Reynier, 2017, European journal of cancer.

Use of Tamoxifene-Controlled Ovarian Hyperstimulation for fertility preservation before breast cancer treatment: a prospective cohort study with a 5-year follow-up

A. Dezellus, F. Leperlier, A. Gremeau, 2024, The Breast.